Sign in

CIK 0001360214 · Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
450567010
Phone
615.733.4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. SC 13D Stake Beneficial Ownership Report
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Results of operations
  4. 10-Q Report Quarterly Report
  5. 8-K Event Other events
  6. 8-K Event Agreement ended
  7. 4 Open-market sale Director sold 10,000 shares at $4.21 ($42,100)
  8. 8-K Event Regulation FD disclosure
  9. 4 Open-market sale Director sold 10,000 shares at $3.00 ($30,000)
  10. SC 13G Stake Amended Statement of Ownership
  11. 4 Open-market sale Director sold 10,000 shares at $3.00 ($30,000)
  12. 4 Open-market sale Director sold 130,000 shares at $3.00 ($390,000)
  13. 8-K Event Other events
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Results of operations
  16. 10-Q Report Quarterly Report
  17. 8-K Event Other events
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 22 of 44 · 872 filings